Biodexa Pharmaceuticals (BDRX) announced the appointment of Dr Gary Shangold as Chief Medical Officer with immediate effect. Most recently, Shangold was Chief Medical Officer of Enteris BioPharma, a wholly owned subsidiary of SWK Holdings Corporation (SWKH).
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BDRX:
- Biodexa Pharmaceuticals files to sell 35.875M ADS for holders
- Biodexa Pharmaceuticals Secures Flexible $35 Million Funding Agreement
- Biodexa Pharmaceuticals price target raised to $18 from $8 at Ladenburg
- Biodexa Pharmaceuticals Adjusts Share Value Amid Drug Development Focus
- Biodexa Pharmaceuticals announces result of general meeting
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue